United Microelectronics
UMC
23.31
+0.12
+0.52%
United Microelectronics
US · UMC
#408 by market cap
Listed 2000
23.31
+0.12
+0.52%
Live - 5344 symbols - heartbeat 41s ago
· 2026-10-08 07:00
Pre-market
22.97
-1.47%
After-hours
23.35
+0.17%
Overnight
22.54
-3.30%
- Market cap
- 58.69B
- P/E (TTM)i
- 22.57
- P/Bi
- 4.22
- EPSi
- 0.51
- Div yieldi
- 0.00%
- 52W posi
- 76%
Reader sentiment
Are you bullish or bearish on UMC?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 1.55, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +2.26% YoY
Margins
- Gross margin
- 29.01%
- Operating margin
- 18.38%
- Net margin
- 16.99%
Key ratios & quality
- Enterprise valuei
- -15.27B
- Altman Z-Scorei
- 1.55
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 151.25B | 148.20B | 176.82B | 213.01B | 278.71B | 222.53B | 232.30B | 237.55B |
| Gross profit | 22.84B | 21.31B | 39.00B | 72.05B | 125.76B | 77.74B | 75.65B | 68.91B |
| Selling & admin expenses | 8.84B | 9.13B | 10.82B | 12.66B | 13.86B | 10.70B | 9.82B | 9.23B |
| Research & development | 13.03B | 11.86B | 12.90B | 12.93B | 12.95B | 13.28B | 15.62B | 17.72B |
| Operating profit | 5.75B | 5.36B | 20.20B | 51.35B | 103.62B | 57.29B | 51.27B | 43.66B |
| Pretax profit | 2.12B | 4.81B | 22.54B | 58.50B | 109.63B | 68.45B | 57.04B | 48.08B |
| Tax | -1.13B | 230.35M | 1.69B | 7.92B | 19.33B | 8.31B | 8.37B | 7.90B |
| Net profit | 3.25B | 4.58B | 20.85B | 50.58B | 90.30B | 60.14B | 48.67B | 40.18B |
| Basic EPS | 3 | 4 | 10 | 21 | 37 | 25 | 20 | 17 |
| Diluted EPS | 3.00 | 3.25 | 9.35 | 20.95 | 35.80 | 24.10 | 19.70 | 16.35 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 57.86B | 58.76B | 59.13B | 61.81B | 61.04B | 68.73B |
| Gross profit | 15.45B | 16.88B | 17.62B | 18.96B | 17.82B | 22.32B |
| Selling & admin expenses | 2.16B | 2.27B | 2.34B | 2.45B | 2.52B | 3.16B |
| Research & development | 3.96B | 4.19B | 4.63B | 4.94B | 4.58B | 4.75B |
| Operating profit | 9.72B | 10.77B | 11.01B | 13.36B | 11.22B | 14.88B |
| Pretax profit | 9.35B | 10.15B | 14.64B | 13.94B | 16.64B | 45.19B |
| Tax | 1.60B | 1.31B | -300.31M | 5.29B | 526.85M | 2.96B |
| Net profit | 7.74B | 8.85B | 14.94B | 8.64B | 16.12B | 42.22B |
| Basic EPS | 3 | 4 | 6 | 4 | 6 | 17 |
| Diluted EPS | 3.10 | 3.55 | 5.95 | 3.75 | 6.45 | 16.85 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 141.19B | 153.83B | 164.31B | 233.27B | 252.37B | 216.80B | 189.68B | 204.78B |
| Cash & ST investments | 84.19B | 98.57B | 109.57B | 170.90B | 178.60B | 144.88B | 115.24B | 128.37B |
| Inventory | 18.20B | 21.71B | 22.55B | 23.01B | 31.07B | 35.71B | 35.78B | 37.23B |
| Total assets | 362.60B | 366.26B | 366.45B | 450.96B | 524.65B | 546.58B | 560.17B | 567.27B |
| Total current liabilities | 50.02B | 72.96B | 79.48B | 108.25B | 112.61B | 101.90B | 77.40B | 89.53B |
| Short-term debt | 13.10B | 12.59B | 11.61B | 2.48B | 537.31M | 14.04B | 9.15B | 9.03B |
| Long-term debt | 67.08B | 47.89B | 24.77B | 39.83B | 39.88B | 45.24B | 55.53B | 45.37B |
| Total liabilities | 158,199,746,000.00 | 163,347,778,000.00 | 143,314,539,000.00 | 186,580,294,000.00 | 201,834,635,000.00 | 202,859,864,000.00 | 194,462,244,000.00 | 201,362,691,000.00 |
| Total equity | 204.40B | 202.91B | 223.14B | 264.38B | 322.81B | 343.72B | 365.71B | 365.91B |
| Retained earnings | 66.28B | 37.87B | 53.43B | 83.16B | 169.73B | 176.39B | 184.23B | 184.17B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 192.32B | 195.17B | 192.85B | 204.78B | 216.44B | 230.26B |
| Cash & ST investments | 116.87B | 123.65B | 119.04B | 128.37B | 134.26B | 147.39B |
| Inventory | 35.42B | 34.02B | 35.18B | 37.23B | 38.65B | 37.92B |
| Total assets | 572.96B | 548.14B | 555.40B | 567.27B | 599.93B | 665.97B |
| Total current liabilities | 72.87B | 110.39B | 82.28B | 89.53B | 79.61B | 106.31B |
| Short-term debt | 7.14B | 21.91B | 16.70B | 9.03B | 4.22B | 3.45B |
| Long-term debt | 44.63B | 41.60B | 53.76B | 45.37B | 47.17B | 45.57B |
| Total liabilities | 182,133,652,000.00 | 211,098,060,000.00 | 194,195,228,000.00 | 201,362,691,000.00 | 193,195,750,000.00 | 222,048,583,000.00 |
| Total equity | 390.83B | 337.05B | 361.20B | 365.91B | 406.74B | 443.92B |
| Retained earnings | 197.89B | 166.26B | 181.24B | 184.17B | 207.60B | 217.12B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 50.93B | 54.90B | 65.75B | 90.35B | 145.86B | 86.00B | 93.87B | 99.86B |
| Depreciation & amortization | 52.05B | 49.39B | 48.91B | 47.07B | 44.17B | 40.48B | 48.17B | 59.26B |
| Free cash flow | 30.51B | 35.94B | 37.39B | 40.39B | 62.98B | -8.02B | 2.53B | 49.13B |
| Dividends paid | -8.56B | -6.91B | -9.77B | -19.87B | -37.45B | -45.01B | -37.59B | -35.78B |
| Stock buybacks / issuance | -3.94B | -2.97B | -372.00K | -- | -- | -- | -- | -- |
| Ending cash balance | 83.66B | 95.49B | 94.05B | 132.62B | 173.82B | 132.55B | 105.00B | 110.66B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 23.83B | 22.10B | 20.94B | 33.00B | 21.98B | 33.70B |
| Depreciation & amortization | 14.13B | 14.51B | 14.99B | 15.63B | 15.99B | 16.24B |
| Free cash flow | 9.34B | 13.51B | 8.77B | 17.51B | 8.77B | 24.22B |
| Dividends paid | -- | -- | -- | 3.63M | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 106.35B | 111.99B | 104.22B | 110.66B | 109.02B | 124.71B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 3.72 | 4.01 | 10.74 | 21.04 | 30.51 | 17.93 | 13.76 | 11.04 |
| ROA %i | 2.04 | 2.24 | 6.24 | 12.54 | 18.34 | 11.14 | 8.81 | 7.16 |
| ROIC %i | 3.46 | 3.96 | 9.02 | 18.20 | 26.30 | 14.63 | 11.16 | 9.22 |
| 5-year avg ROE %i | 4.71 | 4.46 | 5.41 | 8.82 | 14.00 | 16.85 | 18.80 | 18.86 |
| EBIT margin %i | 3.23 | 5.22 | 13.88 | 28.34 | 39.97 | 31.42 | 25.28 | 20.88 |
| FCF / sales %i | 20.17 | 24.25 | 21.15 | 18.96 | 22.60 | -- | 1.09 | 20.68 |
| Current ratioi | 2.82 | 2.11 | 2.07 | 2.15 | 2.24 | 2.13 | 2.45 | 2.29 |
| Quick ratioi | 2.18 | 1.72 | 1.75 | 1.91 | 1.93 | 1.75 | 1.95 | 1.82 |
| Debt / assetsi | 22.11 | 18.00 | 11.30 | 10.38 | 8.69 | 11.74 | 12.58 | 10.54 |
| LT debt / equityi | 32.90 | 26.34 | 13.36 | 16.79 | 13.98 | 14.59 | 16.78 | 13.87 |
| Interest coveragei | 1.76 | 2.64 | 12.25 | 32.31 | 62.40 | 47.45 | 34.98 | 32.45 |
| Revenue CAGR (3Y) %i | 1.46 | 0.07 | 5.81 | 12.09 | 23.43 | 7.97 | 2.93 | -5.19 |
| Net income CAGR (3Y) %i | -16.64 | -1.84 | 33.18 | 88.28 | 122.21 | 37.70 | -1.63 | -23.31 |
| FCF CAGR (3Y) %i | -- | -- | 75.19 | 9.81 | 20.56 | -- | -60.29 | -7.94 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 12.00 | 11.90 | 11.44 | 11.04 | 12.23 | 21.03 |
| ROA %i | 8.09 | 7.26 | 7.39 | 7.16 | 8.31 | 13.53 |
| ROIC %i | 10.10 | 9.68 | 9.08 | 9.22 | 10.58 | 18.06 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 23.50 | 20.65 | 19.94 | 20.88 | 23.63 | 36.66 |
| FCF / sales %i | 8.66 | 13.39 | 19.25 | 20.68 | 20.17 | 23.64 |
| Current ratioi | 2.64 | 1.77 | 2.34 | 2.29 | 2.72 | 2.17 |
| Quick ratioi | 2.11 | 1.43 | 1.87 | 1.82 | 2.18 | 1.77 |
| Debt / assetsi | 10.03 | 12.57 | 13.67 | 10.54 | 9.46 | 8.15 |
| LT debt / equityi | 12.88 | 13.95 | 16.40 | 13.87 | 12.91 | 11.45 |
| Interest coveragei | 33.14 | 29.98 | 29.39 | 32.45 | 37.99 | 61.30 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Wafer is the largest reported line at 96.66% of revenue, across 2 reported segments.
- The next-largest line, Others, is a distant second at 3.34% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Wafer96.66%
Others3.34%
Quote time 2026-10-08 07:00:07 · For reference only, not investment advice and not tailored to your situation.